Practical Toolkit for Building a Successful Partnership with High-Risk Hepatitis C Patients

Is your team struggling to engage high-risk patients in hepatitis C virus (HCV) care?

This toolkit contains step-by-step guides to facilitate overcoming stigma and increasing patient engagement in HCV screening, treatment, and self-care, as well as a brief overview of HCV treatment for key groups, including people who inject drugs (PWID), men who have sex with men (MSM), people who are incarcerated, and migrants. These practical tools have been vetted by renowned European HCV experts and are designed for use in primary care clinics, drug treatment centres, medically supervised injecting centres, street-based outreach programmes, and criminal justice settings. Download the free toolkit in your language today.

How to use this toolkit

Partners

Expert Faculty

Marc Bourlière, MD

Associate Professor and Department Head
Department of Hepato-Gastroenterology
Saint-Joseph Hospital
Marseille, France

Graham Foster, FRCP, PhD

Professor of Hepatology
Queen Mary University of London
Consultant Hepatologist
Barts Health NHS Trust
London, United Kingdom

Pietro Lampertico, MD, PhD

Associate Professor of Gastroenterology
Director of the Gastroenterology and Hepatology Division
Head of the A.M. e A. Migliavacca Center for the Study of Liver Disease
University of Milan
Milan, Italy

Jeffrey V Lazarus, PhD, MIH, MA

Barcelona Institute for Global Health (ISGlobal)
Faculty of Medicine
University of Barcelona
Barcelona, Spain

Stephan Walcher, MD, GP

Member, Board of Directors
European Opiate Addiction Treatment Association (EUROPAD)
Director, CONCEPT-Center for Addiction Treatment
Munich, Germany

Please answer these brief questions to continue:

0%

Which of the following best describes you?

Which hepatitis C virus (HCV) healthcare services are you involved with? (select all that apply)

For which patient population do you most need focused training and tools in order to improve patient engagement in HCV care?

For which of the following aspects of HCV care do you need additional training and tools? (select 2)

Which of the following would be most useful to help you and your team address challenges to applying shared decision-making in your daily practice?